Carboplatin and TS-1 combination chemotherapy in cancer of unknown primary site : a phase II multicenter trial
Phase 2
- Conditions
- Cancer of unknown primary site
- Registration Number
- JPRN-UMIN000023961
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
a) favorable subset of CUP b) double cancer c) uncontrollable effusion in pleural or abdominal d) uncontrollable brain metastasis e)sever coexisting illness uncontrollable angina, AMI or congestive heart failure within 3 months, uncontrollable diabetes melitus active infection interstitial pneumonitis in CXR severe psychological problems uncontrollable diarrhea physician assessed the patient as ineligible the patients have to continue flucitocin, phenytoin and warfarin pregnant patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall response rate
- Secondary Outcome Measures
Name Time Method adverse event, survival outcome(OS, PFS)